Integra LifeSciences
#4530
Rank
$1.84B
Marketcap
United States
Country
Mr. Jan De Witte (Pres, CEO & Director)
Ms. Carrie L. Anderson (Exec. VP, CFO & Treasurer)
Mr. Robert T. Davis Jr. (Exec. VP & Pres of Tissue Technologies)
Summary
History
Integra LifeSciences was founded by Richard Caruso in 1989 after Caruso licensed Integra artificial skin technology from Harvard-MIT and acquired Colla-tec, a subsidiary of Marion Laboratories. The company became publicly traded under the NASDAQ ticker name IART.In 1996, Integra artificial skin was approved by the U.S. Food and Drug Administration. The artificial skin, manufactured and patented as Integra, is now used on patients with extensive burns. In 1999, the FDA approved Integra LifeSciences’ DuraGen, an absorbable implant used in neurosurgical and spinal procedures.In 2001, the company received FDA approval for Licox, a brain tissue oxygen and temperature monitor. Licox is used to treat patients in critical care, including those suffering from traumatic brain injuries.In 2002, the FDA approved the use of Integra Dermal Regeneration Template for reconstructive surgery of burn scars. In 2016, IDRT received premarket approval from the FDA for the treatment of diabetic foot ulcers.In 2018, Integra LifeSciences was included in Fortune’s list of Fastest Growing Companies.In 2021, Integra ranked #57 on Medical Design and Outsourcing’s list of largest medical technology companies in the world.
Mission
Vision
Key Team
Mr. Michael J. McBreen (Exec. VP & Pres of Codman Specialty Surgical)
Mr. Jeffrey Mosebrook (Sr. VP, Principal Accounting Officer & Corp. Controller)
Dr. Kenneth E. Burhop Ph.D. (Corp. VP & Chief Scientific Officer)
Mr. William Compton (Chief Information Officer & Corp. VP)
Mr. Eric Ian Schwartz (Exec. VP, Chief Legal Officer & Sec.)
Laurene Isip (VP of Global Corp. Communications & PR)
Ms. Maria Platsis (Sr. VP of Corp. Devel.)
Recognition and Awards
References
https://en.wikipedia.org/wiki/Integra_LifeSciences
https://in.investing.com/equities/integra-lifescien
https://finance.yahoo.com/quote/IART/profile?p=IART
https://www.comparably.com/companies/integra-lifesciences/mission
https://www.crunchbase.com/organization/integra-lifesciences-holdings
https://sec.report/CIK/0000917520
Mr. Jan De Witte (Pres, CEO & Director)
Ms. Carrie L. Anderson (Exec. VP, CFO & Treasurer)
Mr. Robert T. Davis Jr. (Exec. VP & Pres of Tissue Technologies)